SA

Spectral AI, Inc.

MDAI·NASDAQ

$2.01

+0.75%
HealthcareMedical - Devices

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

At a Glance

Live Snapshot
Market Cap$63.97M
EPS-0.2900
P/E Ratio-6.93
Earnings Date08/11/2026

mdai

Total Debt

Last Annual Value

10.09M

3-Year CAGR

103%

5-Year CAGR

202%

10-Year CAGR

74%

SA

Spectral AI, Inc. Competitors Analysis of Total Debt

MDAI · NASDAQ
CompanyTotal Debt
CAGR 3Y
CAGR 5Y
CAGR 10Y
10.09M
98.6%76.9%N/A 
268.88K
-39.7%-42.0%N/A
43.56M
-3.3%11.6%N/A
680.00K
-4.6%24.8%N/A
719.00K
-4.4%-42.8%N/A
1.97M
-44.7%-60.6%-35.0%
732.07K
-10.7%-14.6%N/A
56.36M
10.8%16.3%N/A
18.86M
-3.1%59.8%N/A
233.61M
9.7%5.3%N/A
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
55.65M
9.2%12.1%N/A
SA

Spectral AI, Inc. Fair Value Envelope

MDAI · NASDAQ

Our analysis suggests that MDAI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.01, this represents a potential HIDDEN relative to our calculated worth for Spectral AI, Inc..

Intrinsic Value
Current Price: $2.01